右美托咪定减轻模型大鼠心肌缺血/再灌注损伤

doi:10.16352/j.issn.1001-6325.2025.03.0303

基础医学与临床 ›› 2025, Vol. 45 ›› Issue (3): 303-309.doi: 10.16352/j.issn.1001-6325.2025.03.0303

右美托咪定减轻模型大鼠心肌缺血/再灌注损伤

刘根凤¹, 南璐², 高琴², 陈祎轩², 张静², 余鹏², 余树春^2*

1.赣南医科大学附属兴国医院麻醉科,江西赣州 342400;
2.南昌大学第二附属医院麻醉科,江西南昌 330006

收稿日期:2024-04-19 修回日期:2024-10-31 发布日期:2025-02-25
通讯作者: ^*ncuysc@163.com
基金资助:
国家自然科学基金地区科学基金(82160371);赣鄱俊才支持计划·青年科技人才托举项目(2023QT05)

Dexmedetomidine alleviatesmyocardial ischemia-reperfusion injury in rat models

LIU Genfeng¹, NAN Lu², GAO Qin², CHEN Yixuan², ZHANG Jing², YU Peng², YU Shuchun^2*

1. Department of Anesthesiology, Xingguo Hospital, Gannan Medical University, Ganzhou 342400;
2. Department of Anesthesiology, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China

Received:2024-04-19 Revised:2024-10-31 Published:2025-02-25

摘要/Abstract

摘要： 目的探讨右美托咪定(Dex)对大鼠心肌缺血/再灌注(I/R)损伤的保护及铜死亡在其中的作用机制。方法构建Langendorff模型(I/R组),将大鼠分为:假手术组、I/R+Veh组、I/R+Dex组和I/R+Dex+ES-Cu组。连续监测缺血前即刻(T0)、再灌注(T1)、60(T2)、90 min(T3)和2 h(T4)的左室峰压(LVSP)、左室舒张末压(LVEDP)、心率(HR)、左室压力升高最大速率(+dp/dtmax)与左室压力降低最大速率(-dp/dtmax)。后用1%氯化三苯基四氮唑(TTC)染色显示心肌梗死范围,天狼星红染色评估心肌纤维化程度;ELISA测心肌酶谱、氧化应激和炎性反应;铜离子试剂盒测心肌组织中铜离子含量;Western blot检测ATF3、SPI1和FDX1蛋白表达。结果与假手术组比较, I/R组心肌梗死范围和纤维化程度增大(P＜0.05),血清MDA、IL-6、IL-1β和TNF-α水平升高(P＜0.05),SOD和GSH-Px活性降低(P＜0.05),Dex组能显著缓解 I/R组以上变化,与Dex组比较, Dex+ES-Cu组再灌注末心肌组织铜离子含量升高(P＜0.05),ATF3和SPI1蛋白水平均升高,FDX1蛋白水平降低(P＜0.05)。结论 Dex能调节铜代谢,改善氧化应激反应和炎性反应引起的大鼠心肌缺血/再灌注损伤(MI/RI)。

关键词: 右美托咪定, 铜死亡, 心肌缺血/再灌注损伤(MI/RI), 氧化应激反应, 炎性反应

Abstract: Objective To investigate the relationship between the protective mechanism of dexmedetomidine (Dex) against myocardial ischemia-reperfusion(I/R) injury and cuproptosis. Methods The Langendorff models were constructed using SD rats(I/R group), which were divided into 4 groups according to different interventions during reperfusion as: sham group, I/R group, Dex group and Dex+ES-Cu group. The left ventricular peak pressure(LVSP)of the rats in the above four groups were continuously monitored in the immediate pre-ischemic period(T0), 30 min of reperfusion(T1), 60 min reperfusion(T2), 90 min reperfusion(T3),2 h of reperfusion(T4). Left ventricular end-diastolic pressure(LVEDP), heart rate (HR), maximum rate of rise of left ventricular pressure (+dp/dtmax) and maximum rate of drop. Subsequently, the extent of myocardial infarction was shown by1% triphenyltetrazoliumchloride (TTC) staining, and the degree of myocardial fibrosis was assessed by Sirius red staining; Myocardial enzyme profiles, oxidative stress and inflammation indexes were detected by ELISA; Copper ions were detected by copper ion detection kit in myocardial tissues; ATF3, SPI1 and FDX1 protein level expression was detected by Western blot. Results Compared with the sham-operated group, the extent of myocardial infarction and fibrosis increased in the I/R group(P＜0.05), the level of serum MDA, IL-6, IL-1β, and TNF-α was elevated(P＜0.05), and the activity of SOD and GSH-Px decreased(P＜0.05). The Dex group significantly alleviated the above changes in the I/R group, and compared with the Dex group, in the Dex+ES-Cu group myocardial tissue copper ion content at the end of perfusion was increased(P＜0.05). Both ATF3 and SPI1 protein were increased and FDX1 protein was decreased(P＜0.05). Conclusions Dex can regulate copper metabolism and improve myocardial ischemia-reperfusion injury(MI/RI) resulted from oxidative stress and inflammation in rat model.

Key words: dexmedetomidine, cuproptosis, myocardial ischemia-reperfusion injury(MI/RI), oxidative stress, inflammation

中图分类号:

R310.99

刘根凤, 南璐, 高琴, 陈祎轩, 张静, 余鹏, 余树春. 右美托咪定减轻模型大鼠心肌缺血/再灌注损伤[J]. 基础医学与临床, 2025, 45(3): 303-309.

LIU Genfeng, NAN Lu, GAO Qin, CHEN Yixuan, ZHANG Jing, YU Peng, YU Shuchun. Dexmedetomidine alleviatesmyocardial ischemia-reperfusion injury in rat models[J]. Basic & Clinical Medicine, 2025, 45(3): 303-309.

参考文献

[1] Zhao B, Li D, Zhang S, et al. Dexmedetomidine attenuates cerebral ischemia-reperfusion injury in rats by inhibiting the JNK pathway[J]. Ann Palliat Med, 2021, 10: 6768-6778.
[2] Cong D, Yu Y, Meng Y, et al. Dexmedetomidine (Dex) exerts protective effects on rat neuronal cells injured by cerebral ischemia/reperfusion via regulating the Sphk1/S1P signaling pathway[J]. J Stroke Cerebrovasc Dis, 2023, 32: 106896.doi:10.1016/j.jstrokecerebrovasdis.2022.106896.
[3] Hu B, Tian T, Li XT, et al. Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats[J]. Redox Re, 2023, 28: 2158526.doi:10.1080/13510002.2022.2158526.
[4] Chen ZR, Hong Y, Wen SH, et al. Dexmedetomidine pretreatment protects against myocardial ischemia/reperfusion injury by activating STAT3 signaling[J]. Anesth Analg, 2023, 137: 426-439.
[5] 戴小燕. Langendorff离体心脏灌注模型的制备及应用[J]. 医学综述, 2012, 18: 2036-2039.
[6] Yuan M, Meng XW, Ma J, et al. Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling[J]. Drug Des Devel Ther, 2019, 13: 3137-3149.
[7] Huo S, Wang Q, Shi W, et al. ATF3/SPI1/SLC31A1 signaling promotes cuproptosis induced by advanced glycosylation end products in diabetic myocardial injury[J]. Int J Mol Sci, 2023, 24: 1667.doi:10.3390/ijms24021667.
[8] Xiao Y, Li J, Qiu L, et al. Dexmedetomidine protects human cardiomyocytes against ischemia-reperfusion injury through α2-adrenergic receptor/AMPK-dependent autophagy[J]. Front Pharmacol, 2021, 12: 615424.doi:10.3389/fphar.2021.615424.
[9] 张晓青, 徐雪. 右美托咪啶器官保护作用的研究进展[J]. 基础医学与临床,2012, 32: 844-846.
[10] Tang Y, Jia C, He J, et al. The application and analytical pathway of dexmedetomidine in ischemia/reperfusion injury[J]. J Anal Methods Chem, 2019, 2019: 7158142.doi:10.1155/2019/7158142.
[11] Sun M, Wang R, Xia R, et al. Amelioration of myocardial ischemia/reperfusion injury in diabetes: a narrative review of the mechanisms and clinical applications of dexmedetomidine[J]. Front Pharmacol, 2022, 13: 949754.doi:10.1155/2019/7158142.
[12] Yang K, Ma Y, Xie C, et al. Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway[J]. Heliyon, 2023, 9: e22054.doi:10.1016/j.heliyon.2023.e22054.
[13] Zhang T, Mei Q, Dai S, et al. Use of dexmedetomidine in patients with sepsis: a systematic review and meta-analysis of randomized-controlled trials[J]. Ann Intensive Care, 2022, 12: 81.doi:10.1186/s13613-022-01052-2.
[14] Tao WH, Shan XS, Zhang JX, et al. Dexmedetomidine attenuates ferroptosis-mediated renal ischemia/reperfusion injury and inflammation by inhibiting ACSL4 via α2-AR[J]. Front Pharmacol, 2022, 13: 782466.doi:10.3389/fphar.2022.782466.
[15] Guo Q, Ma M, Yu H, et al. Dexmedetomidine enables copper homeostasis in cerebral ischemia/reperfusion via ferredoxin 1[J]. Ann Med, 2023, 55: 2209735.doi:10.1080/07853890.2023.2209735.

编辑推荐 0

Metrics

阅读次数

全文

HTML			PDF

最新录用	在线预览	正式出版	最新录用	在线预览	正式出版
0	0	0	0	0	13

	来源	本网站

	次数	13
	比例	100%

摘要

最新录用	在线预览	正式出版

0	0	49

	来源	本网站

	次数	49
	比例	100%

右美托咪定减轻模型大鼠心肌缺血/再灌注损伤

Dexmedetomidine alleviatesmyocardial ischemia-reperfusion injury in rat models

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐 0

Metrics

本文评价

[1]	付海卫, 郭微微, 盛芬, 刘东红. 上调miR-338-3p减轻白介素-13诱导的人支气管细胞系BEAS-2B损伤[J]. 基础医学与临床, 2025, 45(3): 346-353.
[2]	王婷婷, 秦海东. 脓毒症相关细胞因子风暴的机制与治疗策略[J]. 基础医学与临床, 2025, 45(2): 263-267.
[3]	姜博文, 马睿, 王鹏, 曲哲, 李爱群. 蓝萼甲素减轻创伤性骨折大鼠炎性反应[J]. 基础医学与临床, 2025, 45(2): 210-215.
[4]	杨文, 李勇, 杨淖绚. 小剂量艾司氯胺酮联合舒芬太尼减轻全髋关节置换术老年患者围手术期炎性反应[J]. 基础医学与临床, 2025, 45(1): 60-64.
[5]	孟德权, 秦欣, 陈玲, 覃军. 白术多糖抑制重症肺炎模型大鼠的炎性反应[J]. 基础医学与临床, 2024, 44(9): 1263-1268.
[6]	蒋苏, 吕新翔, 崔艳红, 吕李婷, 李东霞. 吴茱萸碱对特应性皮炎模型大鼠的治疗作用[J]. 基础医学与临床, 2024, 44(9): 1256-1262.
[7]	钱喜锋, 华潞. 炎性细胞与动脉性肺动脉高压血管重塑[J]. 基础医学与临床, 2024, 44(8): 1080-1087.
[8]	高超, 张润菡, 王伟, 赵曼婷, 焦艳, 李喆. 青蒿琥酯调节cGAS-STING信号通路对抑郁症模型小鼠神经炎性反应的影响[J]. 基础医学与临床, 2024, 44(8): 1126-1132.
[9]	张昊, 孙浩, 廖红. 诱导抑郁症患者小胶质细胞炎性反应的机制[J]. 基础医学与临床, 2024, 44(7): 1029-1033.
[10]	霍岩松, 孙海燕, 庞金磊, 郭向飞, 刘亚静, 冉广原, 何明伟. 臭氧联合低温等离子射频消融术对神经根型颈椎病的疗效[J]. 基础医学与临床, 2024, 44(6): 840-844.
[11]	盛琪, 童瑾. CXCL10/CXCR3轴在急性呼吸窘迫综合征中的作用[J]. 基础医学与临床, 2024, 44(6): 892-896.
[12]	韩惠晶, 吴红, 葛银, 乔娟. 右美托咪定减轻呼吸机相关性肺损伤模型大鼠肺组织损伤[J]. 基础医学与临床, 2024, 44(3): 339-345.
[13]	牟杨, 杨志文. 右美托咪定通过激活AMPK减轻TNF-α诱导人成神经细胞瘤细胞系SH-SY5Y损伤[J]. 基础医学与临床, 2024, 44(2): 147-153.
[14]	杜敬宇, 应站专, 侯宾, 多杰, 赵振. 抑制miR-34a减轻慢性阻塞性肺疾病急性加重期炎性反应[J]. 基础医学与临床, 2024, 44(12): 1670-1677.
[15]	孙娜, 宋琳琳, 池津津, 种璐璐, 王震生, 魏新运. 右美托咪定减轻大鼠的骨质疏松[J]. 基础医学与临床, 2024, 44(12): 1656-1662.